XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMON STOCK
12 Months Ended
Jul. 31, 2022
COMMON STOCK  
COMMON STOCK

NOTE 7 COMMON STOCK

 

During the year ended July 31, 2021, the Company sold 2,667,200 shares of common stock at $0.03 per share for total cash proceeds of $80,000.

 

On July 31, 2021, the Company issued 250,000 shares of common stock in conversion of a $25,000 accounts payable. The shares were value at $0.04, the closing stock price on the date of grant. The Company recognized a $15,000 gain on the conversion.

 

On May 5, 2021, the Company issued 5,000,000 shares of common stock to Foster S Zeiders, per the terms of the agreement with Calihoma Partners LLC (Note 10). The shares are being held by the transfer agent and are disclosed as issued but not outstanding.

 

As discussed in Note 6 a note holder converted his note in full into 3,822,659 shares of common stock during the year ended July 31, 2021.

 

During the year ended July 31, 2022, the Company sold 50,000 shares of common stock at $0.10 per share for total cash proceeds of $5,000. 

 

During the year ended July 31, 2022, the Company sold 1,583,336 shares of common stock at $0.03 per share for total cash proceeds of $47,550.

 

On July 20, 2022, an individual converted a $5,000 loan payable into 200,000 shares of common stock. The shares were valued at $0.03, the closing price on the date of conversion, resulting in the recognition of a $1,000 loss on conversion.

 

As discussed in Note 6 a note holder converted their note in full into 310,000 shares of common stock during the year ended July 31, 2022.

 

As discussed in Note 7 a note holder converted their note in full into 435,000 shares of common stock during the year ended July 31, 2022.

 

Refer to Note 11 for stock issued to related parties.